Shayna E A. Street, et.al., Suppression of lymphoma and epithelial malignancies effected by interferon gamma., The Journal of experimental medicine, 2002, 196

http://rdf.ncbi.nlm.nih.gov/pubmed/12093877

Shayna E A. Street, et.al., Suppression of lymphoma and epithelial malignancies effected by interferon gamma., The Journal of experimental medicine, 2002, 196

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased lymphoma incidence_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0012431CB6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• abnormal tumor morphology_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0003448CB6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• increased sarcoma incidence_Ifng<tm1Ts>/Ifng<tm1Ts>
  http://metadb.riken.jp/0002032B6129S7Ifngtm1TsIfngtm1TsIfngtm1TsIfngtm1Ts
• increased lung adenocarcinoma incidence_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0002027CB6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• decreased tumor latency_Ifng<tm1Ts>/Ifng<tm1Ts>,Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0010308CCgPrf1tm1SdzIfngtm1TsIfngtm1TsIfngtm1TsPrf1tm1SdzPrf1tm1SdzPrf1tm1SdzIfngtm1Ts
• decreased tumor latency_Ifng<tm1Ts>/Ifng<tm1Ts>
  http://metadb.riken.jp/0010308B6129S7Ifngtm1TsIfngtm1TsIfngtm1TsIfngtm1Ts
• increased tumor latency_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0009828CB6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• increased lymphoma incidence_Ifng<tm1Ts>/Ifng<tm1Ts>
  http://metadb.riken.jp/0012431B6129S7Ifngtm1TsIfngtm1TsIfngtm1TsIfngtm1Ts
• increased T cell derived lymphoma incidence_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0002024CB6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• increased B cell derived lymphoma incidence_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0002023C57BL6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• abnormal tumor morphology_Ifng<tm1Ts>/Ifng<tm1Ts>,Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0003448CCgPrf1tm1SdzIfngtm1TsIfngtm1TsIfngtm1TsPrf1tm1SdzPrf1tm1SdzPrf1tm1SdzIfngtm1Ts
• increased lymphoma incidence_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0012431C57BL6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• increased sarcoma incidence_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0002032CB6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• premature death_Ifng<tm1Ts>/Ifng<tm1Ts>,Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0002083CCgPrf1tm1SdzIfngtm1TsIfngtm1TsIfngtm1TsPrf1tm1SdzPrf1tm1SdzPrf1tm1SdzIfngtm1Ts
• decreased tumor latency_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0010308C57BL6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• increased lung adenocarcinoma incidence_Ifng<tm1Ts>/Ifng<tm1Ts>
  http://metadb.riken.jp/0002027C129S7Ifngtm1TsIfngtm1TsIfngtm1TsIfngtm1Ts
• premature death_Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0002083C57BL6Prf1tm1SdzPrf1tm1SdzPrf1tm1SdzPrf1tm1Sdz
• increased lymphoma incidence_Ifng<tm1Ts>/Ifng<tm1Ts>,Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0012431CCgPrf1tm1SdzIfngtm1TsIfngtm1TsIfngtm1TsPrf1tm1SdzPrf1tm1SdzPrf1tm1SdzIfngtm1Ts
• increased tumor latency_Ifng<tm1Ts>/Ifng<tm1Ts>
  http://metadb.riken.jp/0009828C129S7Ifngtm1TsIfngtm1TsIfngtm1TsIfngtm1Ts
• premature death_Ifng<tm1Ts>/Ifng<tm1Ts>
  http://metadb.riken.jp/0002083B6129S7Ifngtm1TsIfngtm1TsIfngtm1TsIfngtm1Ts
• increased T cell derived lymphoma incidence_Ifng<tm1Ts>/Ifng<tm1Ts>
  http://metadb.riken.jp/0002024B6129S7Ifngtm1TsIfngtm1TsIfngtm1TsIfngtm1Ts
• increased B cell derived lymphoma incidence_Ifng<tm1Ts>/Ifng<tm1Ts>,Prf1<tm1Sdz>/Prf1<tm1Sdz>
  http://metadb.riken.jp/0002023CCgPrf1tm1SdzIfngtm1TsIfngtm1TsIfngtm1TsPrf1tm1SdzPrf1tm1SdzPrf1tm1SdzIfngtm1Ts